Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2025 ∙ Mink, S. Wilhelm, F. Cadamuro, J. Reimann, P. Fraunberger, P.
Anti-SARS-CoV-2 Antibodies in Long-COVID-Markers of Protection or Elevated Risk? A Systematic Review
All age groups Healthcare workers COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Li, S. Li, R. Li, Y. Hu, Y. Liu, Y. Qin, J. Qin, Z. Feng, Q. Sheng, Z. Li, C. Peng, J.
Combination of Evans syndrome and COVID-19: a systematic review of reported cases
All age groups COVID-19 Safety
Rating:
Critically low
2025 ∙ Rai, S. Tripathi, S.
Comparative efficacy of leading COVID-19 vaccines: A netwometa-analysis
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Blukacz, A. Obach, A. Vasquez, P. Campana, C. Huerta, C. Bernal, Y. Cabieses, B.
Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis
All age groups Low and Middle Income Countries COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Bachmann, M. Gultekin, N. Stanga, Z. Fehr, J. S. Ulgur, I. I. Schlagenhauf, P.
Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Moore, M. Anderson, L. Schiffer, J. T. Matrajt, L. Dimitrov, D.
Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Zhou, G. Dael, N. Verweij, S. Balafas, S. Mubarik, S. Rengerink, K. O. Pasmooij, A. M. G. van Baarle, D. Mol, P. G. M. de Bock, G. H. Hak, E.
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024
Europe Adolescents Adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Mirza, A. A. Almalki, A. H. Noori, F. A. Neazy, S. A. Dahm, V. Bajin, M. D. Lin, V. Y.
Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis
All age groups COVID-19 Safety
Rating:
Low
2025 ∙ Zhao, T. Xu, Q. Cai, X. Wang, M. Ao, L. Wei, T. Yang, H. Zhang, S. Zhang, X. Jin, S. Wang, X. Feng, X. Zhao, J. Wu, Y. Yang, J. Cui, F.
Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis
Adults Older adults COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Magalhaes, B. A. P. Medeiros Minasi, J. Lobato, R. C. Lemos, L. C. de Britto, L. S. Barros, R. M. de Martinez, A. M. B. da Hora, V. P.
Globally approved vaccines for COVID-19: a systematic review
Adolescents Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
Loading...